Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Editas cashes in on Vertex Cas9 licensing agreement for $57M
Against the backdrop of a Cas9 patent battle that refuses to die, Editas is cashing in a chunk of the rights from Vertex to the tune of $57 million.
James Waldron
Oct 4, 2024 5:06am
BioMarin goes CAMPing, striking RNA deal with biotech
Oct 1, 2024 9:55am
Orion to use Aitia 'digital twins' to help find new cancer drugs
Sep 25, 2024 10:00am
Capricor sells Europe rights to late-stage DMD therapy for $35M
Sep 18, 2024 5:55am
Novo Nordisk signs $530M biobucks deal to sing in Korro's opera
Sep 16, 2024 9:40am
Sanofi's $80M bet on Fulcrum dystrophy drug ends in phase 3 fail
Sep 12, 2024 9:30am